검색어: tolerabiliteten (덴마크어 - 영어)

mad forbedrer tolerabiliteten af tipranavir med ritonavir.
food improves the tolerability of tipranavir with ritonavir.

infusionshastigheden afhang af tolerabiliteten, med en initial infusionsvarighed på 90 minutter.
the rate of infusion was based on tolerability, with an initial infusion duration of 90 minutes.

for at øge tolerabiliteten af betaferon i forsøget med patienter med en første klinisk
betaferon prolonged the time to cdms by 363 days, from 255 days in the placebo group to 618 days in the betaferon group (based on the 25th percentiles) .

på grundlag af disse data forventes tolerabiliteten at være ens for disse to grupper.
based on this data, the tolerability would be expected to be similar between those two groups.

tolerabiliteten af agomelatin hos ældre patienter var sammenlignelig med den, der ses hos yngre voksne.
tolerability of agomelatine in elderly patients was comparable to that seen in the younger adults.

relevante antihistaminer og/eller kortikosteroider kan forbedre tolerabiliteten og fremskynde udslættets forsvinden.
appropriate antihistamines and/or corticosteroids may improve the tolerability and hasten the resolution of rash.

du bør administrere dosen 6 til 9 gange dagligt, i henhold til det individuelle behov og tolerabiliteten.
you should administer the dose 6 to 9 times per day according to individual needs and tolerability.

der findes ingen oplysninger om tolerabiliteten af tolcapon hos disse patientgrupper (se 5. 2).
no information on the tolerability of tolcapone in these populations is available (see 5.2).

generelt anbefales dosistitrering ved behandlingsstart for at øge tolerabiliteten over for betaferon (se sektion 4. 2).
generally, dose titration is recommended at the start of treatment in order to increase tolerability to betaferon (see section 4.2).

for at forbedre tolerabiliteten af bivirkninger fra nervesystemet anbefales dosering ved sengetid (se afsnit 4. 8) .
in order to improve the tolerability of nervous system undesirable effects, bedtime dosing is recommended (see section 4.8) .

da lojuxta doseres ved eskalering i henhold til sikkerheden og tolerabiliteten hos den enkelte patient, anbefales imidlertid ingen justering af dosisregimet baseret på race.
however, since the medicinal product is dosed in an escalating fashion according to individual patient safety and tolerability, no adjustment to the dosing regimen is recommended based on race.

der eksisterer ikke tilstrækkelige data for tolerabiliteten af efavirenz sammen med lav dosis af ritonavir (100 mg 1 eller 2 gange dagligt) .
sufficient data on the tolerability of efavirenz with low-dose ritonavir (100 mg once or twice daily) are not available.

der eksisterer ikke tilstrækkelig med data for tolerabiliteten af efavirenz sammen med lav dosis af ritonavir (100 mg 1 eller 2 gange dagligt) .
sufficient data on the tolerability of efavirenz with low-dose ritonavir (100 mg, once or twice daily) are not available.

5. 2) .dosering ved sengetid synes at forbedre tolerabiliteten af disse symptomer (se pkt.4. 2) .
dosing at bedtime seems to improve the tolerability of these symptoms (see section 4.2) .

effekten af og tolerabiliteten over for inhaleret iloprost, når den administreres med andre nebulisatorsystemer, som giver andre forstøvningskarakteristika af iloprost-opløsningen, er ikke klarlagt.
the efficacy and tolerability of inhaled iloprost when administered with other nebulising systems, which provide different nebulisation characteristics of iloprost solution, have not been established.

sikkerheden og tolerabiliteten for valsartan hos patienter med alvorlig nyreinsufficiens (kreatininclearance < 10 ml/ min) blev ikke vurderet i nogen klinisk undersøgelse.
the safety and tolerability of valsartan in patients with severe renal failure (creatinine clearance of < 10 ml/ min) was not evaluated in any clinical study.

der er udført to multicenterundersøgelser (den ene i usa, den anden i europa), hvor man sammenlignede virkningen, sikkerheden og tolerabiliteten for firocoxib og phenybutazon (i
two multi-centre studies were conducted (one in the usa and one in europe) to compare the efficacy, safety and acceptability of firocoxib under field conditions with that of phenybutazone (in the usa) or vedaprofen (in europe).

tolerabiliteten var sammenlignelig for de to behandlingsarme, men hoste blev oftere rapporteret med ramipril-regimet end med aliskiren-regimet (14,2 % vs.
tolerability was comparable in both treatment arms, however cough was more often reported with the ramipril regimen than the aliskiren regimen (14.2% vs.

66 patienter, der gennemførte det pivotale fase 3-forsøg, deltog i et udvidet forsøg (160902) til evaluering af langtidssikkerheden, -tolerabiliteten og -virkningen af hyqvia ved pid.
66 patients who completed the pivotal phase 3 study participated in an extension study (160902) for the evaluation of long-term safety, tolerability and efficacy of hyqvia in pid.